We think Roche's drug portfolio and industry-leading diagnostics conspire to create maintainable competitive advantages. As the market leader in both biotech and diagnostics, this Swiss healthcare giant is uniquely positioned to guide global healthcare toward a safer, more personalized, and more cost-effective future. Strong information sharing continues between Genentech and Roche researchers, boosting research and development productivity and personalized medicine offerings that leverage Roche's diagnostic expertise and leadership in artificial intelligence.